IMAGING DIAGNOSTIC SYSTEMS INC /FL/
NT 10-Q, 1998-05-15
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Previous: NATIONS FUND INC, 497, 1998-05-15
Next: TECH DATA CORP, DEF 14A, 1998-05-15




<TABLE>
<CAPTION>
<S>                                                                                                 <C>
                                                                                                    -----------------------------
                                                                                                            OMB APPROVAL
                                           SECURITIES AND EXCHANGE COMMISSION                       -----------------------------
                                                Washington, D.C. 20549                              OMB Number:        
                                                                                                    Expires:        
                                                                                                    Estimated average burden
                                                      FORM 12b-25                                   hours per response ..... 2.50
                                                                                                    -----------------------------
                                                                                                    -----------------------------
                                             NOTIFICATION OF LATE FILING                               COMMISSION FILE NUMBER
                                                                                                              0-26028
(Check One):  [ ] Form 10-K [ ] Form 20-F [ ] Form 11-K [X] Form 10-Q [ ] Form N-SAR                -----------------------------
                                                                                                    -----------------------------
                                                                                                             CUSIP NUMBER
                                                                                                                45244W
     For Period Ended: March 31, 1998                                                          -----------------------------

     [ ] Transition Report on Form 10-K
     [ ] Transition Report on Form 20-F
     [ ] Transition Report on Form 11-K
     [ ] Transition Report on Form 10-Q
     [ ] Transition Report on Form N-SAR

     For the Transition Period Ended: ___________________________________________________________________________________________

- ------------------------------------------------------------------------------------------------------------------------------------
                            Read Instruction (on back page) Before Preparing Form. Please Print or Type.

         Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.
- ------------------------------------------------------------------------------------------------------------------------------------

If the notification relates to a portion of the filing checked above, identify the item(s) to which the notification relates:

____________________________________________________________________________________________________________________________________

PART I -- REGISTRANT INFORMATION

      Imaging Diagnostic Systems, Inc.
____________________________________________________________________________________________________________________________________
Full Name of Registrant

____________________________________________________________________________________________________________________________________
Former Name if Applicable

    6531 NW 18th Court
____________________________________________________________________________________________________________________________________
Address of Principal Executive Office (Street and Number)

   Plantation, FL. 33313
____________________________________________________________________________________________________________________________________
City, State and Zip Code

PART II -- RULE 12b-25(b) AND (c)

If the subject report could not be filed without  unreasonable  effort or expense and the registrant  seeks relief  pursuant to Rule
12b-25(b), the following should be completed. (Check appropriate box.)

  [ ]  (a) The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable
           effort or expense;
        
  [X]  (b) The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-SAR,
           or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed  due date; or the
           subject quarterly report or transition report on Form 10-Q, or portion thereof will be filed on or before the fifth
           calendar day following the prescribed due date; and
        
  [ ]  (c) The accountant's statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.
</TABLE>

<PAGE>

PART III -- NARRATIVE

State below in reasonable detail why the Form 10-K, 11-K, 20-F 10-Q, N-SAR, or
the transition report or portion thereof, could not be filed within the
prescribed time period. (Attach Extra Sheets if Needed.)

Independent Auditor could not review for timely filing.
- --------------------------------------------------------------------------------
<PAGE>

<TABLE>
<CAPTION>

PART IV--OTHER INFORMATION

<C> <S>                                                                             
(1) Name and telephone number of person to contact in regard to this notification

              Allan Schwartz                                    (954)                                  581-9800
    ____________________________________________  _______________________________  _________________________________________________
                  (Name)                                    (Area Code)                             (Telephone Number)

(2) Have all other periodic reports required under Section  13 or 15(d) of  the Securities Exchange Act of
    1934 or Section 30  of the  Investment  Company Act of 1940 during the preceding 12 months or for such 
    shorter  period that  the  registrant was required to file such report(s) been filed? If the answer 
    is no, identify report(s).                                                                                [X]  Yes  [ ] No

    --------------------------------------------------------------------------------------------------------------------------------

(3) Is it anticipated that any significant change in results of operations from the corresponding period
    for the last fiscal year will be reflected by the earnings  statements to be included in the subject                      
    report or portion thereof?                                                                                [ ] Yes   [X] No  
    
    If so, attach an explanation of the anticipated change, both narratively and  quantitatively, and, if appropriate, state the
    reasons why a reasonable estimate of the results cannot be made.



====================================================================================================================================

                                                    Imaging Diagnostic Systems, Inc.
                                        ____________________________________________________
                                            (Name of Registrant as Specified in Charter)

has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.


Date: May 15, 1998                                   By:  /s/ Allan L. Schwartz
                                                          ------------------------
                                                           Executive Vice President
                                                           Chief Financial Officer


INSTRUCTION:  The form may be signed by an executive officer of the registrant or by any other duly authorized  representative.  The
name and title of the person signing the form shall be typed or printed beneath the signature.  If the statement is signed on behalf
of the registrant by an authorized representative (other than an executive officer), evidence of the representative's  authority to
sign on behalf of the registrant shall be filed with the form.

- ----------------------------------------------------------- ATTENTION --------------------------------------------------------------
             Intentional misstatements or omissions of fact constitute Federal Criminal Violations (See 18 U.S.C. 1001).
- ------------------------------------------------------------------------------------------------------------------------------------
</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission